Publications by authors named "K D Popov"

Article Synopsis
  • * The study involved 597 patients, finding a low 30-day mortality rate of 0.7%, significant improvements in heart function, and good long-term survival rates at 1, 5, and 10 years.
  • * Results indicate that both single and repeated ASA procedures had similar outcomes in terms of survival and heart function over time, suggesting effectiveness in the treatment of HCM.
View Article and Find Full Text PDF
Article Synopsis
  • Chikungunya virus (CHIKV) is a mosquito-borne virus causing major outbreaks, with no FDA-approved treatments available.
  • Researchers optimized a screening assay for CHIKV's essential protein nsP2 and identified 153 potential drug candidates, including RA-0002034.
  • RA-0002034 effectively inhibits CHIKV nsP2 activity and viral replication, making it a promising compound for future therapeutic development against CHIKV and similar viruses.
View Article and Find Full Text PDF

Despite their widespread impact on human health, there are no approved drugs for combating alphavirus infections. The heterocyclic β-aminomethyl vinyl sulfone RA-0002034 () is a potent irreversible covalent inhibitor of the alphavirus nsP2 cysteine protease with broad-spectrum antiviral activity. Analogs of that varied each of the three regions of the molecule were synthesized to establish structure-activity relationships for the inhibition of (CHIKV) nsP2 protease and viral replication.

View Article and Find Full Text PDF

Despite their widespread impact on human health there are no approved drugs for combating alphavirus infections. The heterocyclic β-aminomethyl vinyl sulfone RA-0002034 () is a potent irreversible covalent inhibitor of the alphavirus nsP2 cysteine protease with broad spectrum antiviral activity. Analogs of that varied each of three regions of the molecule were synthesized to establish structure-activity relationships for inhibition of (CHIKV) nsP2 protease and viral replication.

View Article and Find Full Text PDF

We introduce STOPLIGHT, a web portal to assist medicinal chemists in prioritizing hits from screening campaigns and the selection of compounds for optimization. STOPLIGHT incorporates services to assess 6 physiochemical and structural properties, 6 assay liabilities, and 11 pharmacokinetic properties, for any small molecule represented by its SMILES string. We briefly describe each service and illustrate the utility of this portal with a case study.

View Article and Find Full Text PDF